COLD CAPSULE IV Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Cold Capsule Iv, and what generic alternatives are available?
Cold Capsule Iv is a drug marketed by Graham Dm and is included in one NDA.
The generic ingredient in COLD CAPSULE IV is chlorpheniramine maleate; phenylpropanolamine hydrochloride. There are twenty-nine drug master file entries for this compound. Additional details are available on the chlorpheniramine maleate; phenylpropanolamine hydrochloride profile page.
Summary for COLD CAPSULE IV
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 1 |
Raw Ingredient (Bulk) Api Vendors: | 2 |
Clinical Trials: | 2,304 |
Patent Applications: | 20 |
Formulation / Manufacturing: | see details |
DailyMed Link: | COLD CAPSULE IV at DailyMed |
Recent Clinical Trials for COLD CAPSULE IV
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
Brigham and Women's Hospital | Phase 1 |
MRCF Pty Ltd | Phase 2 |
Lawson Health Research Institute | N/A |
Anatomical Therapeutic Chemical (ATC) Classes for COLD CAPSULE IV
US Patents and Regulatory Information for COLD CAPSULE IV
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Graham Dm | COLD CAPSULE IV | chlorpheniramine maleate; phenylpropanolamine hydrochloride | CAPSULE, EXTENDED RELEASE;ORAL | 018793-001 | Apr 25, 1985 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |